Thomas Steyer’s Ascendis Pharma A/S ASND Stock Holding History

Thomas Steyer’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,400	Closed	-$299K	–	176
2025 Q4	$299K	Hold	1,400	–	–	﹤0.01%	111
2025 Q3	$278K	Hold	1,400	–	–	﹤0.01%	108
2025 Q2	$242K	Hold	1,400	–	–	﹤0.01%	115
2025 Q1	$218K	Buy	+1,400	New	+$200K	﹤0.01%	118
2024 Q4	–	Sell	-1,400	Closed	-$209K	–	155
2024 Q3	$209K	Buy	+1,400	New	+$189K	﹤0.01%	141
2024 Q2	–	Sell	-109,000	Closed	-$16.5M	–	171
2024 Q1	$16.5M	Buy	+109,000	New	+$15.6M	0.07%	81
2021 Q3	–	Sell	-375,000	Closed	-$49.3M	–	303
2021 Q2	$49.3M	Sell	375,000 -625,000	-63%	-$83.3M	0.2%	73
2021 Q1	$129M	Hold	1,000,000	–	–	0.64%	42
2020 Q4	$167M	Sell	1,000,000 -250,000	-20%	-$41.3M	1%	39
2020 Q3	$193M	Buy	1,250,000 +110,000	+10%	+$15.8M	1.33%	29
2020 Q2	$169M	Sell	1,140,000 -236,349	-17%	-$32.5M	1.35%	30
2020 Q1	$155M	Buy	1,376,349 +97,349	+8%	+$12.6M	1.33%	28
2019 Q4	$178M	Sell	1,279,000 -271,000	-17%	-$30.1M	1.2%	27
2019 Q3	$149M	Buy	1,550,000 +10,000	+0.6%	+$1.12M	1.13%	27
2019 Q2	$177M	Buy	1,540,000 +40,000	+3%	+$4.79M	1.15%	23
2019 Q1	$177M	Buy	1,500,000 +703	+0%	+$61.6K	1.33%	24
2018 Q4	$93.9M	Buy	1,499,297 +42,000	+3%	+$2.64M	0.69%	35
2018 Q3	$103M	Hold	1,457,297	–	–	0.61%	34
2018 Q2	$96.9M	Buy	1,457,297 +170,497	+13%	+$11.2M	0.6%	38
2018 Q1	$84.2M	Buy	+1,286,800	New	+$72.3M	0.58%	37

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Thomas Steyer's ASND Position: Q1 2026 in Review

Thomas Steyer sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 1,400 shares — an estimated $299K sold.

Thomas Steyer first reported a position in ASND in Q1 2018 and held it in 20 quarters. The position peaked at $193M in Q3 2020. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

Thomas Steyer reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
Thomas Steyer sold 1,400 Ascendis Pharma A/S shares in Q1 2026, an estimated $299K.
Thomas Steyer first reported a position in Ascendis Pharma A/S in Q1 2018 and held it in 20 quarters.
Thomas Steyer's Ascendis Pharma A/S position peaked at $193M in Q3 2020.
274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.